Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma. (Q45329896)
Jump to navigation
Jump to search
scientific article published in December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma. |
scientific article published in December 2008 |
Statements
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma (English)
Jair Bar
Rinat Yerushalmi
Roni Shapira-Frummer
Irena Kutchuk
Aaron Sulkes
Haim Gutman
1 December 2008